A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Clinical trial NCT03622593 · COMPLETED
Trial details
- NCT number
- NCT03622593
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2020-10-19
- Enrollment
- 951
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.